Safety of manufactured nanomaterials

ProSafe project: science based support for regulation of manufactured nanomaterials


The joint scientific conference of the Horizon2020 Coordination and Support Action ProSafe and OECD “Science based support for regulation of manufactured nanomaterials” was held on 29 Nov to 1 Dec 2016 at the OECD Conference Centre in Paris, France.


The ProSafe Project

The ProSafe project (02/2015-04/2017) is an EU H2020 coordination and support action (CSA), which coordinated and strengthened existing and new initiatives in the field of nanosafety (risk assessment, management and governance). This was done by streamlining data acquisition, collection and management on regulatory orientated toxicology testing of nanomaterials, exposure monitoring, LCA, and disposal and treatment of waste nanomaterials). It emphasised the regulatory policy developments, on both the national and international level, including challenges raised by the convergence between nano and biotechnologies.



The objective of the conference was to discuss the regulatory relevance of new research and initiatives results in the field of nanosafety and to identify the outstanding and future regulatory challenges.

The conference was organised across 4 main themes:

  • Nanomaterials identification and characterisation
  • Exposure and Fate
  • Nanomaterials Hazard
  • Nanomaterials Tiered testing and Tools for Risk Assessment

For this aim scientists, risk assessors, and legal advisors from EU member states and OECD member states involved in FP7/H2020 projects or OECD WPMN activities met and discussed in groups the regulatory relevant areas of concern, including physicochemical identification and characterisation, exposure, fate and kinetics, ecological and health effects as well as testing and assessment strategies.

This report summarises the discussions at the conference and highlights the findings of the experts. It also includes summaries of the presented lectures and a plenary panel discussion. It features a compilation of conclusions and recommendations for regulatory questions regarding assessing risk for human health and environment.

More information can be found on The Dutch National Institute for Public Health and the Environment (RIVM)


Related Documents